LUTEX
Timeline
22 events since 2013The 2026 accounts are due by 31-01-2027.
appointed as statutory director“A) à toutes prestations de services et tous mandats sous forme d'études, d'organisation, d'expertises, d'actes…” (deed in French) · General meeting of 13-11-20206 points ▸
- General meeting of 13-11-2020
- Purpose change, “A) à toutes prestations de services et tous mandats sous forme d'études, d'organisation, d'expertises, d'actes techniques, de conseils et d'avis financiers…” (deed in French)
- The capital is divided into 250 shares
- appointed as statutory director
- Power of attorney granted to
- Power of attorney granted to (proxy holder)
- The deed holds 4 more points.
Resignations & appointments appointed as statutory manager · General meeting of 03-10-20173 points ▸
- Incorporation, 30-12-2013
- General meeting of 03-10-2017
- appointed as statutory manager
- The deed holds 4 more points.
Merger: 3P DALHEM takes over PHARMAFORM, PIRON FRERES and LUTEXCompany renamed from 3P DALHEM to LUTEX · “H) L'importation, l'exportation, l'achat, la vente, le stockage, la distribution, la transformation et le…” (deed in French) · The company holds all the shares of PHARMAFORM · General meeting of 16-12-20146 points ▸
- General meeting of 16-12-2014
- The company holds all the shares of PHARMAFORM
- The company holds all the shares of PIRON FRERES
- The company holds all the shares of LUTEX
- Name change, LUTEX
- Purpose change, “H) L'importation, l'exportation, l'achat, la vente, le stockage, la distribution, la transformation et le négoce en général sous quelque forme que ce soit, de…” (deed in French)
- The deed holds 3 more points.
Merger proposal: 3P DALHEM takes over PIRON FRERESThe company holds all the shares of PIRON FRERES5 points ▸
- Merger by absorption
- The capital is divided into 250 shares
- The capital is divided into 150 shares
- The company holds all the shares of PIRON FRERES
- The operation takes effect in the accounts on 01-01-2014
- The deed holds 9 more points.
Merger proposal: 3P DALHEM takes over LUTEXThe company holds all the shares of LUTEX7 points ▸
- Merger by absorption
- The capital is divided into 250 shares
- The capital is divided into 300 shares
- The company holds all the shares of LUTEX
- The operation takes effect in the accounts on 01-01-2014
- The capital is divided into 100 shares
- The company holds all the shares of PHARMAFORM
- The deed holds 8 more points.
IncorporationFounding capital of €56,775.27, 250 shares · Demerger: PIRON splits off to 3P DALHEM · appointed as manager · published on 10-01-20145 points ▸
- The capital is €56,775.27, divided into 250 shares
- appointed as manager
- The founding capital is €56,775.27, divided into 250 shares
- The capital was increased by €56,275.27
- The operation takes effect in the accounts on 31-12-2012
- The deed holds 12 more points.
Financial milestones sit on the financial year-end date, not the filing date.
A deed published in both Dutch and French appears here once.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
LUTEX was incorporated on 31 December 2013, with a starting capital of €56,775.12 In 2014 the company absorbed LUTEX, PHARMAFORM and PIRON FRERES by merger.3 The board currently has 2 members, 2 of whom have served since 2013.4 Total assets went from €7.4m in 2019 to €7.0m in 2025 and headcount from 3.9 to 3 full-time equivalents.5